Nanologica will participate at Spotlight Next’s company day on Thursday Nov 18. The event can be viewed on the link below and Nanologica will be the first company to present, at 12.30 :
FINANSIELL SAMMANFATTNING Nettoomsättningen för tredje kvartalet uppgick till 2 119 TSEK (2 089) och för niomånadersperioden till 12 238 TSEK (10 064) Rörelseresultatet för kvartalet uppgick till -11 718 TSEK (-5 795) och för niomånadersperioden till -26 581 TSEK (-15 924) Resultatet efter skatt för kvartalet uppgick till -12 546 TSEK (-5 899) och för niomånadersperioden till -29 607 TSEK (-16 772) Resultat per aktie före och efter utspädning var -0,45 SEK (-0,21) för kvartalet och
Nanologica will exhibit on BCEIA (Beijing Conference and Exhibition an Instrumental Analysis) held in Beijing Sep 27-29. BCEIA is a world exposition on analytical science and biochemical technology that attracted more than 25,000 registered participants in 2017.
Nanologica presents at Erik Penser Bank on September 16 at 09.15. You can watch the presentation on the link:
In Nanologica’s stock option program 2018/21 exercise of rights in Nanologica’s stock option program has increased the number of shares in the company by 371,346 to 28,165,826 shares. As a result, the share capital increases to SEK 11,548,761. At Nanologica’s Annual General Meeting on May 31, 2018, it was resolved to establish an incentive program of a maximum of 484,883 stock options for the company’s employees. Each option entitles the holder to subscribe for one
On June 3 at 12.30, Nanologica will present at Erik Penser Bank’s company day. To view the presentation, please follow the link.
